# ARHGEF2

## Overview
ARHGEF2 is a gene that encodes the Rho/Rac guanine nucleotide exchange factor 2, a protein integral to the regulation of Rho GTPases, which are pivotal in controlling cytoskeletal dynamics. This protein functions as a guanine nucleotide exchange factor (GEF), facilitating the exchange of GDP for GTP on Rho GTPases, thereby activating them. The protein is characterized by several domains, including a Dbl homology (DH) domain and a Pleckstrin homology (PH) domain, which are essential for its exchange activity and membrane association, respectively (Ravindran2017Homozygous). ARHGEF2 is involved in various cellular processes, such as mitotic spindle orientation, cell polarity, and cytokinesis, through its interactions with other proteins and its regulation by phosphorylation (Sandí2017MARK3mediated; Birkenfeld2007GEFH1). Mutations in ARHGEF2 have been linked to neurodevelopmental disorders and inflammatory diseases, highlighting its clinical significance (Ravindran2017Homozygous; Olivier2024CCDC88B). Additionally, its role in cancer, particularly in hepatocellular carcinoma, underscores its potential as a therapeutic target (Zhu2022ARHGEF2EDN1).

## Structure
ARHGEF2, also known as Rho/Rac guanine nucleotide exchange factor 2, is a protein involved in the regulation of Rho GTPases, which are critical for cytoskeletal dynamics. The protein contains several domains, including a Dbl homology (DH) domain responsible for its guanine nucleotide exchange activity, and a Pleckstrin homology (PH) domain that aids in membrane association (Ravindran2017Homozygous). It also includes a phorbolester/Diacyl Glycerol-type zinc finger domain and a coiled-coil domain (Ravindran2017Homozygous).

Post-translational modifications such as phosphorylation play a significant role in regulating ARHGEF2's activity. MARK3 phosphorylates ARHGEF2 at Ser 151, creating a 14-3-3 binding site, which affects its interaction with the dynein motor light chain DYNLT1 and influences its subcellular localization and activation (Sandí2017MARK3mediated). This phosphorylation serves as a reversible switch, impacting ARHGEF2's function in cell growth and polarity (Sandí2017MARK3mediated). Other phosphorylation sites include Ser 143, Ser 149, Thr 152, Thr 153, and Ser 163, which are potential modulators of its interaction with DYNLT1 (Sandí2017MARK3mediated).

The protein may have multiple splice variant isoforms, contributing to its functional diversity, although specific details on these isoforms are not provided in the context. The structural analysis of ARHGEF2 has been conducted using techniques such as NMR spectroscopy and x-ray diffraction to study its interactions and phosphorylation status (Sandí2017MARK3mediated).

## Function
ARHGEF2, also known as Rho/Rac guanine nucleotide exchange factor 2, plays a critical role in regulating the RhoA/ROCK/MLC pathway, which is essential for cytoskeletal dynamics and neurogenesis. In healthy human cells, ARHGEF2 is involved in the orientation of the mitotic spindle, a process crucial for determining the fate of neuronal precursors and influencing whether they undergo self-renewal or differentiation. Proper spindle orientation, facilitated by ARHGEF2, promotes asymmetric cell divisions necessary for neurogenesis (Ravindran2017Homozygous).

ARHGEF2 also contributes to cell polarity and cytoskeletal organization through its phosphorylation by MARK3. This phosphorylation promotes the formation of stress fibers and focal adhesions, which are vital for cell adhesion and movement. In 3D cultures, ARHGEF2 is necessary for maintaining cell polarity and epithelial cyst formation, as it influences the distribution of tight junction proteins like ZO-1 and ZO-2 (Sandí2017MARK3mediated).

Additionally, ARHGEF2 is involved in the regulation of RhoA activity during cytokinesis, particularly in the ingression of the contractile furrow. It localizes to cortical microtubules and the midbody region, facilitating RhoA activation necessary for cell division (Birkenfeld2007GEFH1).

## Clinical Significance
Mutations in the ARHGEF2 gene have been linked to several neurodevelopmental disorders. A homozygous frameshift mutation in ARHGEF2 is associated with intellectual disability, midbrain-hindbrain malformation, and mild microcephaly. This mutation disrupts the RhoA/ROCK/MLC pathway, crucial for neuronal migration and brain development, leading to aberrant migration of precerebellar neurons and other developmental abnormalities (Ravindran2017Homozygous).

ARHGEF2 is also implicated in inflammatory diseases. It is part of a genetic locus associated with susceptibility to inflammatory bowel disease (IBD). The gene interacts with CCDC88B and RASAL3, forming a complex that regulates dendritic cell migration, which is crucial in neuroinflammation and colitis. Mutations in ARHGEF2 can affect the migration of inflammatory cells, potentially influencing the severity of these conditions (Olivier2024CCDC88B).

In cancer, particularly hepatocellular carcinoma (HCC), ARHGEF2 is involved in cell proliferation, angiogenesis, and drug resistance. Its upregulation is linked to poor prognosis and resistance to treatments like lenvatinib, suggesting that ARHGEF2 could be a target for therapeutic intervention in HCC (Zhu2022ARHGEF2EDN1).

## Interactions
ARHGEF2, also known as Rho/Rac guanine nucleotide exchange factor 2, is involved in various protein interactions that are crucial for its function in cytoskeletal dynamics and cell polarity. It interacts with MARK3, a kinase that phosphorylates ARHGEF2 at Ser 151 and Ser 885, creating binding sites for 14-3-3 proteins. This phosphorylation modulates ARHGEF2's interactions with other proteins, such as DYNLT1, by altering its subcellular localization and binding affinity (Sandí2017MARK3mediated).

ARHGEF2 also interacts with microtubule-associated proteins like CLASP1 and CLASP2, which are involved in microtubule dynamics and cell polarity (Sandí2017MARK3mediated). The interaction with DYNLT1 is characterized by a specific peptide region on ARHGEF2, and phosphorylation at Ser 151 by MARK3 affects this interaction by creating a competitive binding site for 14-3-3 proteins (Sandí2017MARK3mediated).

Additionally, ARHGEF2 forms complexes with proteins such as CCDC88B and RASAL3, as demonstrated in co-immunoprecipitation studies, indicating its role in broader signaling networks (Olivier2024CCDC88B). These interactions highlight ARHGEF2's role in regulating cell shape, motility, and polarity through its influence on the cytoskeleton.


## References


[1. (Ravindran2017Homozygous) Ethiraj Ravindran, Hao Hu, Scott A. Yuzwa, Luis R. Hernandez-Miranda, Nadine Kraemer, Olaf Ninnemann, Luciana Musante, Eugen Boltshauser, Detlev Schindler, Angela Hübner, Hans-Christian Reinecker, Hans-Hilger Ropers, Carmen Birchmeier, Freda D. Miller, Thomas F. Wienker, Christoph Hübner, and Angela M. Kaindl. Homozygous arhgef2 mutation causes intellectual disability and midbrain-hindbrain malformation. PLOS Genetics, 13(4):e1006746, April 2017. URL: http://dx.doi.org/10.1371/journal.pgen.1006746, doi:10.1371/journal.pgen.1006746. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1006746)

[2. (Olivier2024CCDC88B) Jean-Frederic Olivier, David Langlais, Thiviya Jeyakumar, Maria J. Polyak, Luc Galarneau, Romain Cayrol, Hua Jiang, Kelly R. Molloy, Guoyue Xu, Harumi Suzuki, John LaCava, Philippe Gros, and Nassima Fodil. Ccdc88b interacts with rasal3 and arhgef2 and regulates dendritic cell function in neuroinflammation and colitis. Communications Biology, January 2024. URL: http://dx.doi.org/10.1038/s42003-023-05751-9, doi:10.1038/s42003-023-05751-9. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-023-05751-9)

[3. (Sandí2017MARK3mediated) María-José Sandí, Christopher B. Marshall, Marc Balan, Étienne Coyaud, Ming Zhou, Daniel M. Monson, Noboru Ishiyama, Arun A. Chandrakumar, José La Rose, Amber L. Couzens, Anne-Claude Gingras, Brian Raught, Wei Xu, Mitsuhiko Ikura, Deborah K. Morrison, and Robert Rottapel. Mark3-mediated phosphorylation of arhgef2 couples microtubules to the actin cytoskeleton to establish cell polarity. Science Signaling, October 2017. URL: http://dx.doi.org/10.1126/scisignal.aan3286, doi:10.1126/scisignal.aan3286. This article has 44 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1126/scisignal.aan3286)

[4. (Zhu2022ARHGEF2EDN1) Yue Zhu, Weiwei Liu, Zishu Wang, Yanfei Wang, Chaisheng Tan, Zhipeng Pan, Anqi Wang, Jiatao Liu, and Guoping Sun. Arhgef2/edn1 pathway participates in er stress-related drug resistance of hepatocellular carcinoma by promoting angiogenesis and malignant proliferation. Cell Death &amp; Disease, July 2022. URL: http://dx.doi.org/10.1038/s41419-022-05099-8, doi:10.1038/s41419-022-05099-8. This article has 6 citations.](https://doi.org/10.1038/s41419-022-05099-8)

[5. (Birkenfeld2007GEFH1) Jörg Birkenfeld, Perihan Nalbant, Benjamin P. Bohl, Olivier Pertz, Klaus M. Hahn, and Gary M. Bokoch. Gef-h1 modulates localized rhoa activation during cytokinesis under the control of mitotic kinases. Developmental Cell, 12(5):699–712, May 2007. URL: http://dx.doi.org/10.1016/j.devcel.2007.03.014, doi:10.1016/j.devcel.2007.03.014. This article has 183 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.devcel.2007.03.014)